Current and emerging drug therapies for the treatment of depression in adults with epilepsy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current and emerging drug therapies for the treatment of depression in adults with epilepsy

Published:2018-11-14 Issue:1 Volume:20 Page:41-45
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Mula Marco¹²,Sander Josemir W.³⁴⁵^ORCID

Affiliation:

1. Institute of Medical and Biomedical Education, St George’s University of London, London, UK

2. Atkinson Morley Regional Neuroscience Centre, St George’s University Hospitals NHS Foundation Trust, London, UK

3. NIHR UCL Hospitals Biomedical Research Centre, UCL Institute of Neurology, London, UK

4. Chalfont Centre for Epilepsy, Chalfont St Peter, UK

5. Stichting Epilepsie Instellingen Nederland - SEIN, Heemstede, Netherlands

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2018.1543402

Reference50 articles.

1. Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan

2. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy

3. Predictors of pharmacoresistant epilepsy

4. Concurrent mood and anxiety disorders are associated with pharmacoresistant seizures in patients with MTLE

5. The Influence of Comorbid Depression on Seizure Severity

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frontiers and hotspots in comorbid epilepsy and depression: a bibliometric analysis from 2003 to 2023;Frontiers in Neurology;2024-06-21

2. Specific dysphoric disorders in epilepsy;Perm Medical Journal;2024-05-23

3. Effect of drug treatment changes and seizure outcomes on depression and suicidality in adults with drug‐resistant focal epilepsy;Epilepsia;2023-12-21

4. Psychiatric symptoms predict drug-resistant epilepsy in newly treated patients;Seizure;2022-12

5. Psychiatric adverse events in three phase III trials of eslicarbazepine acetate for focal seizures;Epilepsia Open;2022-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3